Based on the BIORA THERAPEUT.NEW -001 stock forecast from 0 analysts, the average analyst target price for BIORA THERAPEUT.NEW -001 is not available over the next 12 months. BIORA THERAPEUT.NEW -001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BIORA THERAPEUT.NEW -001 is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, BIORA THERAPEUT.NEW -001’s stock price was EUR 0.51. BIORA THERAPEUT.NEW -001’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -95.57% over the last year.
No recent analyst target price found for BIORA THERAPEUT.NEW -001
No recent average analyst rating found for BIORA THERAPEUT.NEW -001
Company Overview BIORA THERAPEUT.NEW -001
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. Read Less
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of ...Read More
Frequently Asked Questions About BIORA THERAPEUT.NEW -001 (4ZU0:F) Stock
Stock Target Advisor's fundamental analysis for BIORA THERAPEUT.NEW -001's stock is Very Bearish.
Unfortunately we do not have enough data on 4ZU0:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4ZU0:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4ZU0:F's stock to indicate if its overvalued.
The last closing price of 4ZU0:F's stock was EUR 0.51.
The most recent market capitalization for 4ZU0:F is EUR 1.88M.
Unfortunately we do not have enough analyst data on 4ZU0:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BIORA THERAPEUT.NEW -001's stock.
As per our most recent records BIORA THERAPEUT.NEW -001 has 58 Employees.
BIORA THERAPEUT.NEW -001's registered address is 4330 La Jolla Village Drive, San Diego, CA, United States, 92122.
You can get more information about it from BIORA THERAPEUT.NEW -001's website at https://www.bioratherapeutics.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About BIORA THERAPEUT.NEW -001 (4ZU0:F) Stock
Stock Target Advisor's fundamental analysis for BIORA THERAPEUT.NEW -001's stock is Very Bearish.
Unfortunately we do not have enough data on 4ZU0:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4ZU0:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4ZU0:F's stock to indicate if its overvalued.
The last closing price of 4ZU0:F's stock was EUR 0.51.
The most recent market capitalization for 4ZU0:F is EUR 1.88M.
Unfortunately we do not have enough analyst data on 4ZU0:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains BIORA THERAPEUT.NEW -001's stock.
As per our most recent records BIORA THERAPEUT.NEW -001 has 58 Employees.
BIORA THERAPEUT.NEW -001's registered address is 4330 La Jolla Village Drive, San Diego, CA, United States, 92122.
You can get more information about it from BIORA THERAPEUT.NEW -001's website at https://www.bioratherapeutics.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4ZU0:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
